SymbioCellTech, LLC
Cell therapy platform for diabetes treatment using engineered cell lines
New patent ·
- Sector
- Biotech
- Headquarters
- SALT LAKE CITY, UT
- Latest Form D
- $286K, Aug 2017
- Total capital
- $2.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.4M
- 3 Form D · last Aug 2017
- 110 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 13 pending · first 2022
- Rank in peer group#339 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$286K
- Private capital raisedForm D · SEC · 2nd filing$1.9M
- Private capital raisedForm D · SEC · 1st filing$200K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Christof WestenfelderResearcherExecutive Officer, Director, PromoterLinked by 2 patents
- Allen GardnerDirectorNamed in SEC Form D filings
- Anna GoochExecutive Officer, DirectorNamed in SEC Form D filings
- Axel ZanderDirector, PromoterNamed in SEC Form D filings
- George ReissDirectorNamed in SEC Form D filings
- Phil HolmesDirectorNamed in SEC Form D filings
Show all 9 people
- Robert Maddock, IIIDirectorNamed in SEC Form D filings
- Robert Maddock, LLCDirectorNamed in SEC Form D filings
- Susan McKeeverExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 16- New patentNeo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus TherewithUSPTOUS 12,753,392
- PendingSpecies-Specific Tissue Culture Medium for the Propagation of CellsUSPTOApplication 18997284
- GrantedAdaptation of Hollow-Fiber-Based Cell Culture Technology for the Manufacturing of (1) Neo-Islets, Employed for the Treatment of Type 1 and Type 2 Diabetes Mellitus, and (2) the Generation of Exosomes from Various Cell Types, Used in the Treatment of Different Organ Injuries and DiseasesUSPTOUS 12,281,330
Show all 16 patent records
- Neo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus TherewithOct 6, 2026 · US 12,753,392Granted
- Species-Specific Tissue Culture Medium for the Propagation of CellsJul 23, 2026 · Application 18997284Pending
- Adaptation of Hollow-Fiber-Based Cell Culture Technology for the Manufacturing of (1) Neo-Islets, Employed for the Treatment of Type 1 and Type 2 Diabetes Mellitus, and (2) the Generation of Exosomes from Various Cell Types, Used in the Treatment of Different Organ Injuries and DiseasesApr 22, 2025 · US 12,281,330Granted
- Cell Clusters Comprising Stem and Islet Cells, Methods of Making, and Treatment of Diabetes Mellitus TherewithMar 14, 2024 · Application 18263934Pending
- Neo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus TherewithFeb 2, 2023 · Application 17934263Pending
- Neo-islets Comprising Stem And Islet Cells And Treatment Of Diabetes Mellitus TherewithNov 1, 2022 · US 11,485,954Granted
- Cell Clusters Comprising Stem And Islet Cells, Methods Of Making, And Treatment Of Diabetes Mellitus TherewithApplication PCTUS2022015066Pending
- Treatment Of Microvascular Disorders With Mesenchymal Stem Cells And Their ExosomesApplication 62830807Pending
- Adaptation Of Hollow-fiber-based Cell Culture Technology For The Manufacturing Of (1) Neo-islets, Employed For The Treatment Of Type 1 And Type 2 Diabetes Mellitus, And (2) The Generation Of Exosomes From Various Cell Types, Used In The Treatment Of Different Organ Injuries And DiseasesApplication PCTUS2018049950Pending
- Adaptation Of Hollow-fiber-based Cell Culture Technology For The Manufacturing Of (1) Neo-islets, Employed For The Treatment Of Type 1 And Type 2 Diabetes Mellitus, And (2) The Generation Of Exosomes From Various Cell Types, Used In The Treatment Of Different Organ Injuries And DiseasesApplication 62556888Pending
- Neo-islets Comprising Stem And Islet Cells And Treatment Of Diabetes Mellitus TherewithApplication PCTUS2016051105Pending
- Neo-islets Comprising Stem And Islet Cells And Treatment Of Diabetes Mellitus TherewithApplication 62264238Pending
- Symbions Comprising Stem And Islet Cells And Treatment Of Diabetes Mellitus TherewithApplication 62216920Pending
- Stem Cell / Islet Cell Hybrids, Generation Thereof, And Methods For The Treatment And Cure Of Insulin-dependent Diabetes MellitusApplication PCTUS2014061231Pending
- Cell Clusters Comprising Stem And Islet Cells, Methods Of Making, And Treatment Of Diabetes Mellitus TherewithApplication 63145380Pending
- Species-Specific Tissue Culture Medium for the Propagation of CellsApplication 63390842Pending
Related companies, and why
- Clade & Co., Inc.Similar federal contract value in Biotech · null in contracts
- AbbraTech Holdings LLCSimilar federal contract value in Biotech · null in contracts
- Phycin, Inc.Similar federal contract value in Biotech · null in contracts
- Marea TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Belenos Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Brenig TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .